ArticleJournal of diabetes and metabolic disorders2025
Adherence to treatment among patients with type 2 diabetes: short communication.
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Undesirable adherence to treatment is one of most important challenges in the control and treatment of type 2 diabetes. Therefore, the present study was conducted with the aim of determining the level of adherence to treatment and factors affecting it among patients with type 2 diabetes in Tehran. Methods: This cross-sectional descriptive study was conducted in 2023 on 117 patients with diabetes referred to Imam Khomeini Hospital in Tehran. The data collection tool was the Hill-Bone Medication Adherence Scale (HB-MAS), which was completed by the participants. Version 16 SPSS and descriptive analysis at the statistical level of 0.05 were used to analyze the data. Results: The mean age of the participants in this research was 45.06 ± 8.48 years. The results showed that 41.03% of the participants had the desirable treatment adherence and 58.97% had the undesirable treatment adherence. A significant relationship was observed between the compliance of patients with the variables of gender, level of education and job status ( Conclusion: The findings showed that the level of adherence to treatment in patients with type 2 diabetes in Tehran is not undesirable. It is better for the treatment team to take more effective measures to improve the awareness of patients in adherence to treatment. Planners and policy makers should also take more effective measures to empower patients to access health services. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-025-01627-3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.